Cost of care

The End of Humira’s $200 Billion Drug Monopoly

January 26, 2023

What will happen when the best selling drug ever finally faces direct competition?

November 3, 2022

We talk about the impact medical debt can have on people’s lives and what research tells us about possible solutions.

November 1, 2022

Stacie Dusetzina shares new research that examines the link between drug companies’ charity donations and their business incentives.

October 18, 2022

Sayeh Nikpay shares new research that examines the impact of a trauma center boom in Texas.

September 20, 2022

Yaa Akosa Antwi shares new research on the impact of a pay-for-performance program on hospital quality.

September 8, 2022

Congress gave Medicare historic new powers to lower drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.

August 9, 2022

Stacie Duestzina shares key takeaways from the drug pricing provisions of the new Inflation Reduction Act.

July 21, 2022

Independent abortion funds have been flooded with donations post-Roe. How do these funds work and what role will they play in a post-Roe world?

July 7, 2022

Why has a little-known program designed to help hospitals and clinics that serve low-income people become so controversial?

June 21, 2022

Benedic Ippolito shares new research that examines whether hospitals with higher prices also offer higher quality care.